This study focused on two primary areas: 1. To determine what can be learned from biotech and drug development companies that suffered from financial problems and ultimately failed at the beginning of the 21st century. 2. To determine how intellectual capital developed in accordance with such...

The turnover of the companies in North Savo in 2011 was nearly 10 billion euros, of which industry accounted for just under a third. The industrial structure of the region is not strong, but on the other hand it is not alarmingly thin either, because it does have certain successful niches. North...

The turnover of the companies in North Savo in 2011 was nearly 10 billion euros, of which industry accounted for just under a third. The industrial structure of the region is not strong, but on the other hand it is not alarmingly thin either, because it does have certain successful niches. North...

The turnover of the companies in North Savo in 2011 was nearly 10 billion euros, of which industry accounted for just under a third. The industrial structure of the region is not strong, but on the other hand it is not alarmingly thin either, because it does have certain successful niches. North...

Global health care issues are driving the public sector into a balancing act between conflicting and complementary forces of inevitable change: an ageing population, the explosion of new therapeutic technologies, a critical shortage of clinical professionals, the desire to improve clinical...

This report is an overview to the presentations and discussions in the seminar Survival or performance? Healthcare viewed through organization, information management, and personnel held on 3.9.2012. The seminar provided an interdisciplinary forum for the question how the health care system may...

In this paper our aim is to assess the evolution of the Finnish biotechnology sector during the 2000s. Particular focus is given to the growth expectations and realized outcomes of Finnish biotechnology companies, to the evolution of public investments, and to potential determinants of company...

This paper utilizes queuing models to analyze health care processes. We extend previous queuing models to allow for i) heterogeneous resources, ii) resource allocation to various tasks, and iii) teams (complementary resources). We model a process of one clinical unit. We use the model to analyze...